Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
410
-
Total 13F shares, excl. options
-
51,367,353
-
Shares change
-
-1,934,040
-
Total reported value, excl. options
-
$7,335,259,701
-
Value change
-
-$214,457,075
-
Put/Call ratio
-
141%
-
Number of buys
-
240
-
Number of sells
-
169
-
Price
-
$142.95
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2019
As of 31 Mar 2019 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 498 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,367,353 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., FMR LLC, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, TIAA CREF INVESTMENT MANAGEMENT LLC, STATE STREET CORP, Boston Partners, Bank of New York Mellon Corp, and PUTNAM INVESTMENTS LLC.
This table shows 498 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.